TransCode Therapeutics Inc Ordinary Shares RNAZ 深 滬
等待開盤 10-18 09:30:00 美东时间
0.599
-0.080
-11.80%
華盛通- 最 高0.6948
- 今 開0.685
- 成交量 96.47万股
- 最 低 0.5687
- 昨 收 0.6791
- 總市值 1503.35万
- 52周最高 20.688
- 市盈率 靜 --
- 換手率 3.84%
- 52周最低 0.216
- 委 比 37.93%
- 總股本 2509.76万
- 歷史最高 5600.00
- 量 比 0.48
- 振 幅 18.57%
- 歷史最低 0.5687
- 每 手 1
- 風險率 4.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TransCode Therapeutics and Michigan State Target Metastatic Breast Cancer in New Study
TransCode Therapeutics, Inc. (NASDAQ:RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, in collaboration with Michigan State University, published an article in the
09-10 19:06
TransCode Therapeutics secures $2M grant for lead candidate
TransCode Therapeutics (NASDAQ:RNAZ) has been awarded a $2M Direct to Phase II Small Business Innovation Research grant from the National Institutes of Health to support clinical evaluation of TTX-MC1...
09-05 21:49
TransCode Therapeutics Announces Initiation Of Phase 1 Study Of TTX-MC138
TransCode Therapeutics Announces Initiation Of Phase 1 Study Of TTX-MC138
08-15 19:06
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of SAP SE (NYSE:SAP) rose sharply in today's pre-market trading after th...
07-23 17:29
Reported Earlier, TransCode Therapeutics Prices $3M Public Offering Of 10M Common Shares At $0.30/Share
The Company intends to use the net proceeds from the offering primarily for product development activities, including one or more clinical trials with TTX-MC138, its lead therapeutic candidate, and related
07-23 14:21
TransCode Therapeutics announces proposed common stock offering
TransCode Therapeutics (NASDAQ:RNAZ) on Monday announced that it intends to offer to sell shares of its common stock in a best efforts public offering. The offering is subject to market conditions and...
07-23 04:19
TransCode Therapeutics regains compliance with Nasdaq
TransCode Therapeutics (NASDAQ:RNAZ) said it has received notice from Nasdaq, stating that the company has regained compliance with all applicable Nasdaq listing standards. As a result, the company’s ...
06-10 19:12
HC Wainwright & Co.：重申TransCode Therapeutics(RNAZ.US)评级，由买入调整至买入评级, 目标价由3.00美元调整至3.00美元。
HC Wainwright & Co.：重申TransCode Therapeutics(RNAZ.US)评级，由买入调整至买入评级, 目标价由3.0...
05-30 00:42
Sea, DraftKings, Sasol among premarket losers' pack
Marpai (MRAI) -41% on notice of delisting or failure to satisfy a continued listing rule. OneMedNet (ONMD) -20%. Gold Royalty (GROY) -15% after agreeing to acquire a copper stream on the Vares silver ...
05-28 20:48
